3 END MODIFIED OLIGODEOXYNUCLEOTIDES PHOSPHOROTHIOATE - PHARMACOKINETICS AND STABILITY IN MICE

被引：0
|
作者：
TEMSAMANI, J [1 ]
TANG, JY [1 ]
PADMAPRIYA, A [1 ]
KUBERT, M [1 ]
AGRAWAL, S [1 ]
机构：
[1] HYBRIDON INC, WORCESTER, MA 01605 USA
来源：
JOURNAL OF CELLULAR BIOCHEMISTRY | 1993年
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：209 / 209
页数：1
相关论文
共 50 条
  • [41] Phosphorothioate-modified CpG oligodeoxynucleotides mimic autoantigens and reveal a potential role for Toll-like receptor 9 in receptor revision
    Doster, Anne
    Ziegler, Saskia
    Foermer, Sandra
    Rieker, Ralf Joachim
    Heeg, Klaus
    Bekeredjian-Ding, Isabelle
    IMMUNOLOGY, 2013, 139 (02) : 166 - 178
  • [42] Enhancement of anti-herpetic activity of antisense phosphorothioate oligonucleotides 5' end modified with geraniol
    Shoji, Y
    Iwatani, W
    Ishige, H
    Tamura, N
    Norimatsu, M
    Shimada, J
    Mizushima, Y
    23RD INTERNATIONAL SYMPOSIUM ON CONTROLLED RELEASE OF BIOACTIVE MATERIALS, 1996 PROCEEDINGS, 1996, : 263 - 264
  • [43] Pharmacokinetics and biodistribution in mice of matrilysin antisense phosphorothioate oligodeoxynucleotide formed as a therapeutic agent for colon cancer.
    Momiyama, N
    Ichikawa, Y
    Ishikawa, T
    Hasegawa, S
    Mitsuhashi, M
    Shimada, H
    GASTROENTEROLOGY, 1997, 112 (04) : A617 - A617
  • [44] Enhancement of anti-herpetic activity of antisense phosphorothioate oligonucleotides 5′ end modified with geraniol
    Shoji, Y
    Ishige, H
    Tamura, N
    Iwatani, W
    Norimatsu, M
    Shimada, J
    Mizushima, W
    JOURNAL OF DRUG TARGETING, 1998, 5 (04) : 261 - +
  • [45] Effect of poly(ethylene imine) molecular weight and pegylation on organ distribution and pharmacokinetics of polyplexes with oligodeoxynucleotides in mice
    Fischer, D
    Osburg, B
    Petersen, H
    Kissel, T
    Bickel, U
    DRUG METABOLISM AND DISPOSITION, 2004, 32 (09) : 983 - 992
  • [46] Biodistribution, stability and antiviral efficacy of liposome-entrapped phosphorothioate antisense oligodeoxynucleotides in ducks for the treatment of chronic duck hepatitis B virus infection
    Soni, PN
    Brown, D
    Saffie, R
    Savage, K
    Moore, D
    Gregoriadis, G
    Dusheiko, GM
    HEPATOLOGY, 1998, 28 (05) : 1402 - 1410
  • [47] G3139 and other CpG-containing immunostimulatory phosphorothioate oligodeoxynucleotides are potent suppressors of the growth of human tumor xenografts in nude mice
    Gekeler, V
    Gimmnich, P
    Hofmann, HP
    Grebe, C
    Römmele, M
    Leja, A
    Baudler, M
    Benimetskaya, L
    Gonser, B
    Pieles, U
    Maier, T
    Wagner, T
    Sanders, K
    Beck, JF
    Hanauer, G
    Stein, CA
    OLIGONUCLEOTIDES, 2006, 16 (01) : 83 - 93
  • [48] Inhibitory effects of antisense phosphorothioate oligodeoxynucleotides on pancreatic cancer cell Bxpc-3 telomerase activity and cell growth in vitro
    Wang, Yun-Feng
    Guo, Ke-Jian
    Huang, Bei-Ting
    Liu, Yong
    Tang, Xiao-Yun
    Zhang, Jian-Jun
    Xia, Qiang
    WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (25) : 4004 - 4008
  • [49] Inhibitory effects of antisense phosphorothioate oligodeoxynucleotides on pancreatic cancer cell Bxpc-3 telomerase activity and cell growth in vitro
    Yun-Feng Wang
    World Journal of Gastroenterology, 2006, (25) : 4004 - 4008
  • [50] PYRENE-MODIFIED OLIGODEOXYNUCLEOTIDES - ENHANCED DUPLEX BINDING AND STABILITY TOWARDS EXONUCLEASE DEGRADATION INVITRO
    SHIBATA, Y
    MANN, JS
    WOLFE, AR
    MEEHAN, T
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 214 - 214
12345